135 related articles for article (PubMed ID: 34782408)
1. Association of Polypharmacy with Kidney Disease Progression in Adults with CKD.
Kimura H; Tanaka K; Saito H; Iwasaki T; Oda A; Watanabe S; Kanno M; Shimabukuro M; Asahi K; Watanabe T; Kazama JJ
Clin J Am Soc Nephrol; 2021 Dec; 16(12):1797-1804. PubMed ID: 34782408
[TBL] [Abstract][Full Text] [Related]
2. Association of polypharmacy with incidence of CKD: a retrospective cohort study.
Kimura H; Tanaka K; Saito H; Iwasaki T; Watanabe S; Kazama S; Shimabukuro M; Asahi K; Watanabe T; Kazama JJ
Clin Exp Nephrol; 2023 Mar; 27(3):272-278. PubMed ID: 36574106
[TBL] [Abstract][Full Text] [Related]
3. Polypharmacy is a risk factor for mortality, severe chronic kidney disease, and liver disease among privately insured adults with cerebral palsy.
Whitney DG; Schmidt M; Haapala H
J Manag Care Spec Pharm; 2021 Jan; 27(1):51-63. PubMed ID: 33377441
[No Abstract] [Full Text] [Related]
4. Polypharmacy, chronic kidney disease, and incident fragility fracture: a prospective cohort study.
Wakasugi M; Yokoseki A; Wada M; Momotsu T; Sato K; Kawashima H; Nakamura K; Onodera O; Narita I
J Bone Miner Metab; 2022 Jan; 40(1):157-166. PubMed ID: 34729651
[TBL] [Abstract][Full Text] [Related]
5. International prescribing patterns and polypharmacy in older people with advanced chronic kidney disease: results from the European Quality study.
Hayward S; Hole B; Denholm R; Duncan P; Morris JE; Fraser SDS; Payne RA; Roderick P; Chesnaye NC; Wanner C; Drechsler C; Postorino M; Porto G; Szymczak M; Evans M; Dekker FW; Jager KJ; Caskey FJ;
Nephrol Dial Transplant; 2021 Feb; 36(3):503-511. PubMed ID: 32543669
[TBL] [Abstract][Full Text] [Related]
6. CKD Progression and Mortality Among Men and Women: A Nationwide Study in Sweden.
Swartling O; Rydell H; Stendahl M; Segelmark M; Trolle Lagerros Y; Evans M
Am J Kidney Dis; 2021 Aug; 78(2):190-199.e1. PubMed ID: 33434591
[TBL] [Abstract][Full Text] [Related]
7. CKD-Associated Pruritus and Clinical Outcomes in Nondialysis CKD.
Scherer JS; Tu C; Pisoni RL; Speyer E; Lopes AA; Wen W; Menzaghi F; Cirulli J; Alencar de Pinho N; Pecoits-Filho R; Karaboyas A;
Kidney Med; 2024 Jan; 6(1):100754. PubMed ID: 38225976
[TBL] [Abstract][Full Text] [Related]
8. Polypharmacy, chronic kidney disease, and mortality among older adults: A prospective study of National Health and nutrition examination survey, 1999-2018.
Wang X; Yang C; Jiang J; Hu Y; Hao Y; Dong JY
Front Public Health; 2023; 11():1116583. PubMed ID: 37033012
[TBL] [Abstract][Full Text] [Related]
9. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
[TBL] [Abstract][Full Text] [Related]
10. Multiple medication (polypharmacy) and chronic kidney disease in patients aged 60 and older: a pharmacoepidemiologic perspective.
Sutaria A; Liu L; Ahmed Z
Ther Adv Cardiovasc Dis; 2016 Aug; 10(4):242-50. PubMed ID: 26920372
[TBL] [Abstract][Full Text] [Related]
11. Kidney, Cardiac, and Safety Outcomes Associated With α-Blockers in Patients With CKD: A Population-Based Cohort Study.
Hundemer GL; Knoll GA; Petrcich W; Hiremath S; Ruzicka M; Burns KD; Edwards C; Bugeja A; Rhodes E; Sood MM
Am J Kidney Dis; 2021 Feb; 77(2):178-189.e1. PubMed ID: 32920153
[TBL] [Abstract][Full Text] [Related]
12. The association between polypharmacy and health-related quality of life among non-dialysis chronic kidney disease patients.
Adjeroh L; Brothers T; Shawwa K; Ikram M; Al-Mamun MA
PLoS One; 2023; 18(11):e0293912. PubMed ID: 37956162
[TBL] [Abstract][Full Text] [Related]
13. Association of Opioids and Nonsteroidal Anti-inflammatory Drugs With Outcomes in CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) Study.
Zhan M; Doerfler RM; Xie D; Chen J; Chen HY; Diamantidis CJ; Rahman M; Ricardo AC; Sondheimer J; Strauss L; Wagner LA; Weir MR; Fink JC;
Am J Kidney Dis; 2020 Aug; 76(2):184-193. PubMed ID: 32317121
[TBL] [Abstract][Full Text] [Related]
14. Kidney Function, Polypharmacy, and Potentially Inappropriate Medication Use in a Community-Based Cohort of Older Adults.
Secora A; Alexander GC; Ballew SH; Coresh J; Grams ME
Drugs Aging; 2018 Aug; 35(8):735-750. PubMed ID: 30039344
[TBL] [Abstract][Full Text] [Related]
15. Risk of Potentially Inappropriate Medications in Adults With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
Hall RK; Blumenthal JB; Doerfler RM; Chen J; Diamantidis CJ; Jaar BG; Kusek JW; Kallem K; Leonard MB; Navaneethan SD; Sha D; Sondheimer JH; Wagner LA; Yang W; Zhan M; Fink JC;
Am J Kidney Dis; 2021 Dec; 78(6):837-845.e1. PubMed ID: 34029681
[TBL] [Abstract][Full Text] [Related]
16. Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study.
Dobre M; Yang W; Chen J; Drawz P; Hamm LL; Horwitz E; Hostetter T; Jaar B; Lora CM; Nessel L; Ojo A; Scialla J; Steigerwalt S; Teal V; Wolf M; Rahman M;
Am J Kidney Dis; 2013 Oct; 62(4):670-8. PubMed ID: 23489677
[TBL] [Abstract][Full Text] [Related]
17. Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study.
Fu EL; Clase CM; Evans M; Lindholm B; Rotmans JI; Dekker FW; van Diepen M; Carrero JJ
Am J Kidney Dis; 2021 May; 77(5):719-729.e1. PubMed ID: 33246024
[TBL] [Abstract][Full Text] [Related]
18. Association between Serum Inorganic Phosphorus Levels and Adverse Outcomes in Chronic Kidney Disease: The Fukushima CKD Cohort Study.
Oda A; Tanaka K; Saito H; Iwasaki T; Watanabe S; Kimura H; Kazama S; Shimabukuro M; Asahi K; Watanabe T; Kazama JJ
Intern Med; 2022 Jun; 61(11):1653-1662. PubMed ID: 34803092
[TBL] [Abstract][Full Text] [Related]
19. Kidney Failure Risk Equation and Cost of Care in Patients with Chronic Kidney Disease.
Prasad B; Osman M; Jafari M; Gordon L; Tangri N; Ferguson TW; Jin S; Kappel J; Kozakewycz D
Clin J Am Soc Nephrol; 2022 Jan; 17(1):17-26. PubMed ID: 34969699
[TBL] [Abstract][Full Text] [Related]
20. Cancer patterns and association with mortality and renal outcomes in non-dialysis dependent chronic kidney disease: a matched cohort study.
Chinnadurai R; Flanagan E; Jayson GC; Kalra PA
BMC Nephrol; 2019 Oct; 20(1):380. PubMed ID: 31640599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
